Marta
Ferrer Puga
Consultora Médica
Universitat de Barcelona
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Universitat de Barcelona (13)
2022
-
A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 191-199
-
Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750
-
Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens
Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4
2021
-
Aradyal: The spanish multidisciplinary research network for allergic diseases
Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 108-119
2020
-
Identification and Characterization of IgE-Reactive Proteins and a New Allergen (Cic a 1.01) from Chickpea (Cicer arietinum)
Molecular Nutrition and Food Research, Vol. 64, Núm. 19
2019
-
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)
Health and Quality of Life Outcomes, Vol. 17, Núm. 1
2017
-
Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe
Rhinology, Vol. 55, Núm. 1, pp. 34-38
-
Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements
Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144
-
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells
Scientific Reports, Vol. 7, Núm. 1
2016
-
Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study
Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870
-
Comparable actions of omalizumab on mast cells and basophils
Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102
2015
-
Management of urticaria: Not too complicated, not too simple
Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743